New hope for Tough-to-Treat leukemia when standard therapy fails
NCT ID NCT06232655
Summary
This study is testing whether a combination of two drugs, cladribine and venetoclax, can help control acute myeloid leukemia (AML) in adults when a similar previous treatment has stopped working. The trial is for people whose AML has a specific pattern (monocytic) and has come back or not responded to a prior drug combination. Researchers will monitor how well the treatment works and its side effects over multiple treatment cycles.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universtiy of Colorado Hospital
RECRUITINGAurora, Colorado, 80045, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.